Skip to main content
Latest News
December 20, 2019
Bristol-Myers Squibb Receives European Commission Approval for Revlimid® (lenalidomide) in Combination with Rituximab for the Treatment of Adult Patients with Previously Treated Follicular Lymphoma
December 19, 2019
Bristol-Myers Squibb to Announce Results for Fourth Quarter 2019 on February 6, 2020
December 18, 2019
Bristol-Myers Squibb Announces Submission of Biologics License Application for CAR T-Cell Therapy Lisocabtagene Maraleucel (liso-cel) to FDA
Latest Events
Event year list
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
December 8, 2019
08:00 PM ET
Bristol-Myers Squibb at American Society of Hematology Annual Meeting
Webcast
(opens in new window)
View this presentation
(opens in new window)
(
PDF
1.64 MB
)
November 6, 2019
03:10 PM ET
Wolfe Research Healthcare Conference
Webcast
(opens in new window)
October 31, 2019
08:30 AM ET
2019 Third Quarter Results Conference Call
Webcast
(opens in new window)
Press Release
Quarterly Package of Financial Information (XLS)
(opens in new window)
(
Excel
1.66 MB
)
Press Release (PDF)
(opens in new window)
(
PDF
436 KB
)